Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118242) titled 'Laparoscopic Ultrasound-Guided Ablation of Hepatic Portal Tumors via the Laennec Membrane Approach' on Feb. 3.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University
Condition:
Hepatocellular carcinoma, hilar tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-09
Target Sample Size: Observation group:9;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307047
Published by HT Digital Content Services with permission from Health Daily Digest....